S SENSILE MEDICAL
LIVE

Serial Number

98113258

Owner

Sensile Medical AG

Attorney

Andrew M. Smith

Filing Date

Aug 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

S SENSILE MEDICAL Trademark

Serial Number: 98113258 • Registration: 7466487

S SENSILE MEDICAL is a trademark filed by Sensile Medical AG on August 2, 2023. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Sensile Medical AG (7 trademarks)

Fabrikstrasse 10

Entity Type: 99

Trademark Details

Filing Date

August 2, 2023

Registration Date

August 6, 2024

Published for Opposition

May 21, 2024

Goods & Services

medical services, in particular in the field of care for diabetics; medical testing services and medical analysis for the diagnosis and treatment of persons; diagnosis of diseases, in particular diabetic diseases; pharmaceutical advice, medical and pharmaceutical consultancy, particularly in the field of diabetes; medical equipment rental; information, advice and medical consultancy, particularly relating to the treatment and care of diabetes, provision of educational information on diabetes via a website; provision of information on the use of medical testing apparatus and consultancy in the field of medical diagnostics via a website

medical apparatus and instruments, namely, electromagnetic drug delivery apparatus for medical use, infusion and injection devices for administering drugs, drug delivery ports and pumps for delivering drugs beneath the skin; apparatus for analyzing blood and blood plasma; apparatus for extracting and analyzing blood, namely, hematology analyzers, hematology rheometers, blood gas analyzers, biochemistry analyzers, hemagglutinators, and chemiluminescence immunoassay analyzers for medical diagnostic uses; apparatus for diagnoses and for analyses for medical use, in particular glucose meters, devices for measuring blood sugar, namely, blood glucose meters, and glycerin concentration meters;medical apparatus for introducing pharmaceutical preparations into the human body, in particular apparatus for introducing insulin and glucagon, namely, jet injectors for medical use; portable pumps and patch pumps for medical use, in particular mobile and portable pumps and patch pumps for the transcutaneous and subcutaneous administering of drugs and active ingredients for diabetes management, for the treatment of degenerative disorders of the central nervous system, and for therapies that periodically require the delivery of a certain total quantity of a formulated drug; insulin and glucagon pumps; belts for medical use; injectors for medical use, namely, infusion pumps, syringes for injections, and medical fluid injectors for transcutaneous and subcutaneous delivery of medication including insulin and glucagon; injection instruments with needles for injecting insulin and glucagon; brush pens and dispensation devices in the form of injection instruments with needles for accurate, precise dosing and application of medical or cosmetic creams and preparations; medical test kits for diabetes control for clinical or household use

scientific and technological services, namely, scientific research and design in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; scientific and technological services, namely, scientific research and design in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; technological advice in the field of the technology of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; scientific laboratory services; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; industrial analysis of medical equipment for use in the management and treatment of diabetes, growth hormone deficiency, pain therapy, and chemotherapy related medical equipment, and scientific research services; industrial analysis and research services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; bacteriological research services; biological research services; chemical research services; chemical analysis; design and development of products in the field of fluids, mechanics, electronics and software; technical project studies in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; research and development of new products for others; technical research services in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring technology; carrying out scientific feasibility studies; testing of materials; calibration services; quality control for others; design and development of software; installation, maintenance and updating and rental of software; software consultancy, namely, consultation about the maintenance and updating of computer software

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 17, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 17, 2024 CNEA
EXAMINER'S AMENDMENT ENTERED
Apr 17, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 17, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 1, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2023 NWOS
NEW APPLICATION ENTERED
Aug 5, 2023 NWAP